Top Story

EMA panel grants positive opinion for Viekirax-Exviera 8-week treatment

February 27, 2017

AbbVie received a positive opinion for 8-week treatment of genotype 1b chronic hepatitis C with combination Viekirax plus Exviera from the European Committee for Medicinal Products for Human Use of the European Medicines Agency, according to a press release.

“AbbVie continuously strives to expand the utility of our HCV treatments, including investigating a shorter path to virologic cure for people living with HCV,” Michael Severino, MD, executive vice present of research and development and chief scientific officer of AbbVie, said in the release. “With this positive CHMP opinion, we will bring an 8-week treatment option for the many HCV patients with [genotype 1b].”

In the Journals

Vitamin D decreases HCV cell replication, aids virologic response

February 27, 2017
Vitamin D decreased hepatitis C cell replication and appeared significantly associated with rapid virologic response in anti-viral therapy, according to study results…
In the Journals

Pioglitazone improves advanced fibrosis in nonalcoholic steatohepatitis

February 27, 2017
In patients with advanced liver fibrosis with or without diabetes, pioglitazone may halt disease progression to end-stage liver disease, according to data published in…

NeuroVive furthers development of HCC, NASH inhibitors

February 24, 2017
NeuroVive announced two research agreements designed to further develop the company’s new drug compounds in the pipeline for the treatment of nonalcoholic…

Merck announces Zepatier coverage by Ontario, British Columbia

February 24, 2017
Ontario will become the first Canadian province to reimburse for Zepatier in the treatment of chronic hepatitis C, effective Feb. 28, 2017, followed by British Columbia…
More News Headlines »

HCV Updates and Case Challenges for the Rapidly Changing Landscape

This activity is supported by an educational grant from Merck & Co., Inc.

In the past few years, significant progress has been made in the treatment of chronic hepatitis C virus (HCV). Highly…
More »
GI Bookshelf

Chapter 6: Nutrients To Nourish The Organisms: Prebiotics And Fiber

From Probiotics: A Clinical Guide
More »
Meeting News

VIDEO: C-CREST-1 trial shows fixed-dose combo effective at 8 weeks for HCV

November 14, 2016
More »
Current Issues Current Issues
View the Current Issue
HCV Next